David Fram

1.7k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

David Fram is a scholar working on Toxicology, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, David Fram has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 10 papers in Epidemiology and 7 papers in Critical Care and Intensive Care Medicine. Recurrent topics in David Fram's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Sepsis Diagnosis and Treatment (9 papers) and Nosocomial Infections in ICU (6 papers). David Fram is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Sepsis Diagnosis and Treatment (9 papers) and Nosocomial Infections in ICU (6 papers). David Fram collaborates with scholars based in United States, United Kingdom and Canada. David Fram's co-authors include William DuMouchel, Chanu Rhee, Michael Klompas, Sameer S. Kadri, June S. Almenoff, Huai-Chun Chen, Rui Wang, Robert L. Danner, John P. Dekker and Fang Zhang and has published in prestigious journals such as Clinical Infectious Diseases, Critical Care Medicine and Statistics in Medicine.

In The Last Decade

David Fram

30 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use

2020 232 citations Chanu Rhee, Sameer S. Kadri et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Fram United States	16	443	267	153	129	117	30	1.0k
Hojjat Salmasian United States	20	303 0.7×	153 0.6×	110 0.7×	83 0.6×	36 0.3×	66	1.4k
Gino Picelli Netherlands	20	182 0.4×	248 0.9×	25 0.2×	56 0.4×	109 0.9×	41	1.1k
Antonio J. Carcas Spain	22	211 0.5×	101 0.4×	42 0.3×	56 0.4×	17 0.1×	116	1.7k
Thaddeus H. Grasela United States	31	529 1.2×	44 0.2×	70 0.5×	48 0.4×	146 1.2×	100	2.6k
Domenico Motola Italy	25	193 0.4×	369 1.4×	19 0.1×	59 0.5×	70 0.6×	87	1.7k
Robert J. Hunkler United States	23	373 0.8×	30 0.1×	46 0.3×	24 0.2×	605 5.2×	31	1.8k
Flora T. Musuamba Belgium	22	324 0.7×	22 0.1×	29 0.2×	84 0.7×	43 0.4×	48	1.8k
Milo Gatti Italy	24	518 1.2×	92 0.3×	56 0.4×	22 0.2×	308 2.6×	131	1.7k
Michael E. Brier United States	27	335 0.8×	9 0.0×	93 0.6×	61 0.5×	77 0.7×	108	2.4k
Ju‐Yeun Lee South Korea	17	107 0.2×	71 0.3×	45 0.3×	14 0.1×	52 0.4×	135	1.2k

Countries citing papers authored by David Fram

Since Specialization

Citations

This map shows the geographic impact of David Fram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fram more than expected).

Fields of papers citing papers by David Fram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fram. The network helps show where David Fram may publish in the future.

Co-authorship network of co-authors of David Fram

This figure shows the co-authorship network connecting the top 25 collaborators of David Fram. A scholar is included among the top collaborators of David Fram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fram. David Fram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kam, Kai‐Qian, Tom Chen, Sameer S. Kadri, et al.. (2024). Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals. Clinical Infectious Diseases. 80(1). 108–117. 4 indexed citations

Rhee, Chanu, Tom Chen, Sameer S. Kadri, et al.. (2024). Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals. JAMA Network Open. 7(6). e2418923–e2418923. 19 indexed citations

Rhee, Chanu, Rui Wang, Sameer S. Kadri, et al.. (2021). Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals. JAMA Network Open. 4(12). e2138596–e2138596. 45 indexed citations

Rhee, Chanu, Sameer S. Kadri, John P. Dekker, et al.. (2020). Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use. JAMA Network Open. 3(4). e202899–e202899. 232 indexed citations breakdown →

Sobel, Rachel E., William L. Blackwell, David Fram, & Andrew Bate. (2019). A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool. Drug Safety. 42(11). 1365–1376. 1 indexed citations

Rhee, Chanu, Rui Wang, Zilu Zhang, et al.. (2019). Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data. Critical Care Medicine. 47(9). 1169–1176. 66 indexed citations

Rhee, Chanu, Zilu Zhang, Rui Wang, et al.. (2017). 1411: SEPSIS SURVEILLANCE USING SOFA VERSUS ESOFA CRITERIA BASED ON ROUTINE EHR DATA. Critical Care Medicine. 46(1). 689–689. 1 indexed citations

Vanderwall, Dana E., Nancy Yuen, James M. Bailey, et al.. (2011). Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery – the GSK experience. Drug Discovery Today. 16(15-16). 646–653. 8 indexed citations

Curtis, Jeffrey R., Hong Cheng, Elizabeth Delzell, et al.. (2008). Adaptation of Bayesian Data Mining Algorithms to Longitudinal Claims Data. Medical Care. 46(9). 969–975. 30 indexed citations

10.

DuMouchel, William, David Fram, Ramy Mahmoud, et al.. (2008). Antipsychotics, Glycemic Disorders, and Life-Threatening Diabetic Events: A Bayesian Data-Mining Analysis of the FDA Adverse Event Reporting System (1968-2004). Annals of Clinical Psychiatry. 20(1). 21–31. 31 indexed citations

11.

Fram, David, et al.. (2007). Signal detection methodologies to support effective safety management. Expert Opinion on Drug Safety. 6(4). 451–464. 27 indexed citations

12.

Almenoff, June S., Gregory Powell, David Fram, et al.. (2007). Online Signal Management: A Systems-Based Approach That Delivers New Analytical Capabilities and Operational Efficiency to the Practice of Pharmacovigilance. Drug Information Journal. 41(6). 779–789. 6 indexed citations

13.

Skidmore, Frank M., Karen E. Anderson, David Fram, & William J. Weiner. (2007). Psychogenic camptocormia. Movement Disorders. 22(13). 1974–1975. 17 indexed citations

14.

Almenoff, June S., et al.. (2006). Comparative Performance of Two Quantitative Safety Signalling Methods. Drug Safety. 29(10). 875–887. 81 indexed citations

15.

Rolka, Henry, et al.. (2005). Using simulation to assess the sensitivity and specificity of a signal detection tool for multidimensional public health surveillance data. Statistics in Medicine. 24(4). 551–562. 21 indexed citations

16.

DuMouchel, William, et al.. (2004). Association of asthma therapy and churg-strauss syndrome: An analysis of postmarketing surveillance data. Clinical Therapeutics. 26(7). 1092–1104. 49 indexed citations

17.

Almenoff, June S., et al.. (2003). Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting. Pharmacoepidemiology and Drug Safety. 12(6). 517–521. 90 indexed citations

18.

Fram, David, June S. Almenoff, & William DuMouchel. (2003). Empirical Bayesian data mining for discovering patterns in post-marketing drug safety. 3 indexed citations

19.

Wilson, Alan C., et al.. (1981). Multivariate Analysis of Color-Evoked Potentials. Optometry and Vision Science. 58(12). 1207–1222. 3 indexed citations

20.

Fram, David, et al.. (1977). Mission: A Low-Cost Data Management System for the Biomedical Community. PubMed Central. 224–231. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact